Format

Send to

Choose Destination
Haematologica. 2019 Apr 11. pii: haematol.2019.217141. doi: 10.3324/haematol.2019.217141. [Epub ahead of print]

Epstein-Barr virus-associated lymphoproliferative disease during imatinib mesylate treatment for chronic myeloid leukemia.

Author information

1
Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
2
Department of Pathology and Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan.
3
Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan; junkuro@koto.kpu-m.ac.jp.

KEYWORDS:

Chronic Myelogenous Leukemia; Epstein Barr virus; Immunodeficiencies; Lymphoproliferative Disorders; imatinib

PMID:
30975907
DOI:
10.3324/haematol.2019.217141
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center